Effects of lactoferricin B against keratitis-associated fungal biofilms

Journal of Infection and Chemotherapy

Volumn 18, Issue 5, 2012, Pages 698-703

  Sengupta, Jayangshu ^a   Saha, Suman ^a   Khetan, Archana ^a   Sarkar, Sujoy K ^b   Mandal, Santi M ^c  

^a Priyamvada Birla Aravind Eye Hospital   (India)

^b Sanjiban Hospital   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Biofilm eradication; Contact lenses; Keratitis; Lactoferricin B

Indexed keywords

AMPHOTERICIN B; CONTACT LENS SOLUTION; FLUCONAZOLE; LACTOFERRICIN B; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; BIOFILM; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTACT LENS; CONTROLLED STUDY; DEVICE INFECTION; DRUG EFFECT; FUSARIUM SOLANI; IN VITRO STUDY; KERATOMYCOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PLANKTON; QUANTITATIVE ANALYSIS; SESSILE SPECIES;

EID: 84871366649     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0398-3     Document Type: Article

References (26)

1. Agrawal V, Biswas J, Madhavan HN, Mangat G, Reddy MK, Saini, et al. Current perspectives in infectious keratitis. Ind J Ophthalmol. 1994;42:171-92.
2. Saha S, Banerjee D, Khetan A, Sengupta J. Epidemiological profile of fungal keratitis in urban population of West Bengal, India. Oman J Ophthalmol. 2009;2:114-8.
3. Srinivasan M, Gonzales CA, George C. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol. 1997;81:965-71.
4. Chang DC, Grant GB, O'Donnell K, Wannemuehler KA, Noble-Wang J, Rao CY, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296: 953-63.
5. Khor WB, Aung T, Saw SM, Wong TY, Tambyah PA, Tan AL, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006;295:2867-73.
6. Sun Y, Chandra J, Mukherjee P, Szczotka-Flynn L, Ghannoum MA, Pearlman E, et al. Model of contact lens-associated Fusarium keratitis. Invest Ophthalmol Vis Sci. 2010;51:1511-6.
7. Holden BA, Sankaridurg PR, Sweeney DF, Stretton S, Naduvilath TJ, Rao GN. Microbial keratitis in prospective studies of extended wear with disposable hydrogel contact lenses. Cornea. 2005;24:156-61.
8. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284: 1318-22.
9. De Lucca AJ, Walsh TJ. Antifungal peptides: origin, activity, and therapeutic potential. Rev Iberoam Micol. 2000;17:116-20.
10. Mandal SM, Migliolo L, Franco OL, Ghosh AK. Identification of an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation. Peptides. 2011;32:1741-7.
11. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrinderived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci. 2005;62:2588-98.
12. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture and drug resistance. J Bacteriol. 2001;183:5385-94.
13. Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H- tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol. 1998;36: 1450-2.
14. Mowat E, Butcher J, Lang S, Williams C, Ramage G. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol. 2007;56:1205-12.
15. Pierce CG, Uppuluri P, Tristan AR, Wormley FR Jr., Mowat E, Ramage G, Lopez-Ribot JL. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3:1494-500.
16. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA, 1997.
17. Melo AS, Bizerra FC, Freymuller E, Arthington-Skaggs BA, Colombo AL. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol. 2011;49:253-62.
18. Imamura Y, Chandra J, Mukherjee PK, Lattif AA, Szczotka-Flynn LB, Pearlman E, et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother. 2008;52:171-82.
19. Kucharíkova S, Tournu H, Lagrou K, van Dijck P, Bujdáková H. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol. 2011;60: 1261-9.
20. Xu KD, McFeters GA, Stewart PS. Biofilm resistance to antimicrobial agents. Microbiology. 2000;146:547-9.
21. Ramage G, Walle KV, Wickes BL, López-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2000;45: 2475-9.
22. Lynch S, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med. 2000;59:415-28.
23. Bellamy W, Yamauchi K, Wakabayashi H, Takase M, Takakura N, Simamura S, et al. Antifungal properties of lactoferricin B, a peptide derived from the N-terminal region of bovine lactoferrin. Lett Appl Microbiol. 1994;18:230-3.
24. Wakabayashi H, Abe S, Teraguchi S, Hayasawa H, Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother. 1998;42:1587-91.
25. Lupetti A, Paulusma-Annema A, Welling MW, Senesi S, van Dissel JT, Nibbering P. Candidacidal activities of human lactoferrin peptides derived from the N-terminus. Antimicrob Agents Chemother. 2000;44:3257-63.
26. Ueta E, Tanida T, Osaki T. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils. J Pept Res. 2001;57:240-9.